Fecal Microbiota Transplant Capsules May Improve Chronic

Medically reviewed | Published: | Evidence level: 1A
A randomized clinical trial reported that capsules containing fecal microbes from screened healthy donors improved symptoms in people with chronic insomnia. The findings strengthen interest in the gut-brain connection, but fecal microbiota transplantation remains experimental for insomnia and should not replace established care.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Research

Quick Facts

Study Design
Randomized clinical trial
Intervention
Oral donor-microbe capsules
Standard Care
CBT-I remains first-line

Can Fecal Microbiota Transplantation Improve Chronic Insomnia?

Quick answer: An early randomized trial suggests donor-microbe capsules may reduce insomnia symptoms, but larger and longer studies are needed.

The trial, reported in the Journal of Internal Medicine, tested capsules containing fecal microorganisms from carefully screened healthy donors in people with chronic insomnia. Participants receiving the intervention experienced improvement in insomnia symptoms, suggesting that changing the intestinal microbial community may influence sleep.

A randomized design strengthens the evidence compared with observational studies, but one trial cannot establish routine clinical use. Researchers still need to determine which microbial changes matter, whether benefits persist, which patients are most likely to respond and how the treatment compares with cognitive behavioral therapy for insomnia, commonly called CBT-I.

How Could Gut Microbes Affect Sleep?

Quick answer: Gut microorganisms may influence sleep through immune, metabolic, hormonal and nervous-system signaling along the gut-brain axis.

The gut and brain communicate through neural pathways, circulating microbial metabolites, immune signals and hormones. Intestinal microorganisms can affect inflammation and produce or modify compounds involved in brain function, creating biologically plausible pathways through which the microbiome might influence sleep timing, arousal and sleep quality.

However, a plausible mechanism is not proof that a particular organism or microbial mixture treats insomnia. Sleep, diet, medications, stress and underlying illness can all alter the microbiome, making cause and effect difficult to separate. Laboratory analyses and independent clinical trials will be necessary to identify whether specific microbial changes mediate the reported improvement.

Is Fecal Microbiota Transplantation Safe for Insomnia?

Quick answer: It should be considered experimental for insomnia because donor material can transmit infectious organisms and other long-term risks remain uncertain.

Fecal microbiota transplantation requires rigorous donor screening, laboratory testing, controlled processing and medical supervision. The US Food and Drug Administration has issued safety communications after pathogenic and drug-resistant organisms were transmitted through fecal microbiota products, including cases involving serious illness.

People should not attempt homemade transplantation or purchase unregulated microbiome products to treat sleep problems. CBT-I remains the recommended first-line treatment for chronic insomnia, while clinicians may also assess contributing conditions such as sleep apnea, restless legs syndrome, depression, pain, medication effects and unhealthy sleep schedules.

Frequently Asked Questions

Fecal microbiota transplantation is not an established insomnia treatment. The new findings require confirmation, and any research use should occur through a properly regulated clinical trial with screened donor material and medical oversight.

Major clinical guidelines recommend cognitive behavioral therapy for insomnia as first-line care. CBT-I addresses sleep schedules, behaviors and unhelpful beliefs about sleep without exposing patients to the risks of donor-derived biological material.

References

  1. Medical Xpress. Fecal microbe transplantation may improve sleep in people with chronic insomnia. July 2026.
  2. Journal of Internal Medicine. Randomized clinical trial report on fecal microbiota transplantation for chronic insomnia. 2026.
  3. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. 2016.
  4. US Food and Drug Administration. Safety communications on the risk of serious infections from fecal microbiota transplantation.